Moreover, the predicted influence of the studied metalloproteins on the activity of 5′ adenosine monophosphate-activated protein kinase (AMPK, p53 activator), cathepsin B, and matrix metalloproteinase (MMP)-9 (cancer migration-related proteases) was evaluated. The gene discussed is TP53; the disease is cancer.